Theralase Technologies (TSE:TLT) has released an update.
Theralase Technologies Inc., a pharmaceutical company focusing on treating cancers, bacteria, and viruses with light-activated compounds, reminds shareholders of its upcoming Annual General and Special Meeting. The meeting will take place on June 19th, 2024, at the company’s head office and will feature a virtual presentation, including a corporate update and a Q&A session for shareholders. An archived version of the event will later be available on the company’s website.
For further insights into TSE:TLT stock, check out TipRanks’ Stock Analysis page.
